SC
Siri Chandana Gangasani
About Siri Chandana Gangasani
Data last updated:
Siri Chandana Gangasani is a Director at Lalitha Super Specialities Hospital Private Limited (since 2022) and Director at Lalitha Pvs Institute Of Medical Sciences Private Limited (since 2020). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹92.87 Cr; the largest is Lalitha Super Specialities Hospital Private Limited at ₹84.77 Cr (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Lalitha Super Specialities Hospital Private Limited U33100AP1999PTC032368 | Director | 01 Jul 2022 | 1999 | ₹84.77 Cr (FY 2022) | Active |
 Lalitha Pvs Institute Of Medical Sciences Private Limited U73100AP2020PTC116189 | Director | 24 Oct 2020 | 2020 | ₹8.10 Cr (FY 2023) | Active |
Board colleagues of Siri Chandana Gangasani
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Siri Chandana Gangasani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Siri Chandana Gangasani
Siri Chandana Gangasani currently holds 2 directorships: Lalitha Super Specialities Hospital Private Limited (Director, since 01 Jul 2022, revenue ₹84.77 Cr (FY 2022)); Lalitha Pvs Institute Of Medical Sciences Private Limited (Director, since 24 Oct 2020, revenue ₹8.10 Cr (FY 2023)).
Siri Chandana Gangasani was first appointed on 24 Oct 2020 as Director at Lalitha Pvs Institute Of Medical Sciences Private Limited. The most recent appointment on record is 01 Jul 2022 at Lalitha Super Specialities Hospital Private Limited.
The 2 current companies of Siri Chandana Gangasani that report revenue have a combined latest revenue of ₹92.87 Cr: Lalitha Super Specialities Hospital Private Limited ₹84.77 Cr (FY 2022); Lalitha Pvs Institute Of Medical Sciences Private Limited ₹8.10 Cr (FY 2023).
The current boards of Siri Chandana Gangasani's companies include Byrapaneni Sravanthi (Lalitha Super Specialities Hospital Private Limited), Polavarapu Anurag (Lalitha Super Specialities Hospital Private Limited), Polavarapu Naren (Lalitha Super Specialities Hospital Private Limited), Veera Raghava Sarma Polavarapu (Lalitha Super Specialities Hospital Private Limited), Vijaya Pamidimukkala (Lalitha Super Specialities Hospital Private Limited), Vijay Kumar Jannada (Lalitha Pvs Institute Of Medical Sciences Private Limited).